Literature DB >> 22139131

Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells.

C Zhong1, C Li, X Wang, T Toyoda, G Gao, Z Fan.   

Abstract

The influenza A virus is a causative agent of influenza, which infects human cells and uses host factors to accomplish viral genome replication as part of its life cycle. The nucleoprotein (NP) and PB2 of the influenza virus associate with importin α1 to gain access to the host nucleus through a ternary import complex. Killer cell-mediated cytotoxicity is the primary mechanism of eliminating the influenza virus. Here, we showed that lymphokine-activated killer cells participated in the elimination of the influenza virus. Granzyme (Gzm) K inhibition elevated viral replication in vitro and aggravated viral infection in vivo. We identified that importin α1 and its transport partner protein importin β are physiological substrates of GzmK. Proteolysis of these two substrates wrecked their association to generate the importin α1/β dimer and disrupted transportation of viral NP to the nucleus, leading to inhibition of influenza virus replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139131      PMCID: PMC3321629          DOI: 10.1038/cdd.2011.178

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  34 in total

1.  Structure of importin-beta bound to the IBB domain of importin-alpha.

Authors:  G Cingolani; C Petosa; K Weis; C W Müller
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 2.  Importin alpha: a multipurpose nuclear-transport receptor.

Authors:  David S Goldfarb; Anita H Corbett; D Adam Mason; Michelle T Harreman; Stephen A Adam
Journal:  Trends Cell Biol       Date:  2004-09       Impact factor: 20.808

Review 3.  Nucleocytoplasmic transport: the soluble phase.

Authors:  I W Mattaj; L Englmeier
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

Authors:  D J Topham; R A Tripp; P C Doherty
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

5.  The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal.

Authors:  P Wang; P Palese; R E O'Neill
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.

Authors:  Zusen Fan; Paul J Beresford; David Y Oh; Dong Zhang; Judy Lieberman
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

7.  Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis.

Authors:  Denis Martinvalet; Pengcheng Zhu; Judy Lieberman
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

Review 8.  Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Authors:  P C Doherty; D J Topham; R A Tripp; R D Cardin; J W Brooks; P G Stevenson
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

9.  Ser624 of the PA subunit of influenza A virus is not essential for viral growth in cells and mice, but required for the maximal viral growth.

Authors:  T Toyoda; K Hara; Y Imamura
Journal:  Arch Virol       Date:  2003-09       Impact factor: 2.574

Review 10.  The importin β binding domain as a master regulator of nucleocytoplasmic transport.

Authors:  Kaylen Lott; Gino Cingolani
Journal:  Biochim Biophys Acta       Date:  2010-10-26
View more
  16 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 2.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

Review 3.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

4.  Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes.

Authors:  Annette C Wensink; Vera Kemp; Job Fermie; M Isabel García Laorden; Tom van der Poll; C Erik Hack; Niels Bovenschen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

5.  Infection history determines the differentiation state of human CD8+ T cells.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Niels J M Verstegen; Pleun Hombrink; Anja ten Brinke; Hanspeter Pircher; Neeltje A Kootstra; Ineke J M ten Berge; René A W van Lier
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

Review 6.  Diversification of importin-α isoforms in cellular trafficking and disease states.

Authors:  Ruth A Pumroy; Gino Cingolani
Journal:  Biochem J       Date:  2015-02-15       Impact factor: 3.857

7.  Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.

Authors:  R van Domselaar; S A H de Poot; E B M Remmerswaal; K W Lai; I J M ten Berge; N Bovenschen
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

8.  Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells.

Authors:  S Liu; H Zhang; M Li; D Hu; C Li; B Ge; B Jin; Z Fan
Journal:  Cell Death Differ       Date:  2012-11-16       Impact factor: 15.828

Review 9.  The effector T cell response to influenza infection.

Authors:  Matthew M Hufford; Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

10.  Natural killer cells in patients with severe chronic fatigue syndrome.

Authors:  E W Brenu; S L Hardcastle; G M Atkinson; M L van Driel; S Kreijkamp-Kaspers; K J Ashton; D R Staines; S M Marshall-Gradisnik
Journal:  Auto Immun Highlights       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.